Nordicus Partners Corp (NORD)

[e-ore]

Based on my research they've been somewhat a victim of circumstances beyond their control. Problems with companies they sell to. Carroll bought over $40,000 on the open market at .14. My opinion is that she expected the improved product sales to continue. The large product sales in 2015 were, imo, sales of raw materials to Access Scientific for the Powerwand catheter. Apparently Access Scientific still has the supply because even though Access Scientific has signed two major distribution agreements and has multiple variations of the Powerwand now available for sale they haven't needed to purchase large amounts of new raw materials from ASNB. Access Scientific was bought and then dumped by a hedge fund and are on their 3rd CEO in the last year.
But ASNB'a apparent inability to commercialize their products to new customers is their biggest problem. Their products have been selected for numerous studies, used in new patent applications by others, and used for new drug delivery studies. All for nought. And if their antimicrobial patent for Chronoflex is effective, and it appears to be with over 22,000 days of catheter use without a single infection, you'd think they'd be a takeover target. But it appears that the use of it is exclusive to Access Scientific, so if one of their other customers (Bard, for example), wanted to buy it they'd have to buy both companies. Imo